Huntington disease and the huntingtin protein

Progress in Molecular Biology and Translational Science

Volumn 107, Issue , 2012, Pages 189-214

  Zheng, Zhiqiang ^a   Diamond, Marc I ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aggregation; Huntingtin; Huntington disease; Keywords; Mitochondrial dysfunction; Mouse models; Posttranslational modification; Protein misfolding; Proteolytic cleavage; Therapeutic approaches; Transcriptional dysregulation

Indexed keywords

EID: 84859609686     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385883-2.00010-2     Document Type: Chapter

References (174)

1. G. Bates, P. Harper, and L. Jones Huntington's disease 2002 Oxford University Press New York
2. A.E. Harding Molecular genetics and clinical aspects of inherited disorders of nerve and muscle Curr Opin Neurol Neurosurg 5 1992 600 604
3. W.R. Kennedy, M. Alter, and J.H. Sung Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait Neurology 18 1968 671 680
4. A.R. La Spada, E.M. Wilson, D.B. Lubahn, A.E. Harding, and K.H. Fischbeck Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy Nature 352 1991 77 79 (Pubitemid 21896702)
5. M. Katsuno, H. Adachi, A. Kume, M. Li, Y. Nakagomi, and H. Niwa Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy Neuron 35 2002 843 854
6. M. Duyao, C. Ambrose, R. Myers, A. Novelletto, F. Persichetti, and M. Frontali Trinucleotide repeat length instability and age of onset in Huntington's disease Nat Genet 4 1993 387 392 (Pubitemid 23231488)
7. F.O. Walker Huntington's disease Lancet 369 2007 218 228 (Pubitemid 46107685)
8. S.E. Andrew, Y.P. Goldberg, B. Kremer, H. Telenius, J. Theilmann, and S. Adam The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease Nat Genet 4 1993 398 403 (Pubitemid 23231490)
9. D.C. Rubinsztein, D.E. Barton, B.C. Davison, and M.A. Ferguson-Smith Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat number Hum Mol Genet 2 1993 1713 1715 (Pubitemid 23358694)
10. R.R. Brinkman, M.M. Mezei, J. Theilmann, E. Almqvist, and M.R. Hayden The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size Am J Hum Genet 60 1997 1202 1210 (Pubitemid 27194105)
11. Y.A. Grimbergen, M.J. Knol, B.R. Bloem, B.P. Kremer, R.A. Roos, and M. Munneke Falls and gait disturbances in Huntington's disease Mov Disord 23 2008 970 976
12. E. van Duijn, E.M. Kingma, and R.C. van der Mast Psychopathology in verified Huntington's disease gene carriers J Neuropsychiatry Clin Neurosci 19 2007 441 448 (Pubitemid 350156103)
13. M. Politis, N. Pavese, Y.F. Tai, S.J. Tabrizi, R.A. Barker, and P. Piccini Hypothalamic involvement in Huntington's disease: an in vivo PET study Brain 131 2008 2860 2869
14. S. Kloppel, S.M. Henley, N.Z. Hobbs, R.C. Wolf, J. Kassubek, and S.J. Tabrizi Magnetic resonance imaging of Huntington's disease: preparing for clinical trials Neuroscience 164 2009 205 219
15. I.J. Mitchell, A.J. Cooper, and M.R. Griffiths The selective vulnerability of striatopallidal neurons Prog Neurobiol 59 1999 691 719 (Pubitemid 29457588)
16. E.H. Aylward, J. Brandt, A.M. Codori, R.S. Mangus, P.E. Barta, and G.J. Harris Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons Neurology 44 1994 823 828 (Pubitemid 24158794)
17. E.H. Aylward, B.F. Sparks, K.M. Field, V. Yallapragada, B.D. Shpritz, and A. Rosenblatt Onset and rate of striatal atrophy in preclinical Huntington disease Neurology 63 2004 66 72 (Pubitemid 38943780)
18. J.P. Vonsattel Huntington disease models and human neuropathology: similarities and differences Acta Neuropathol 115 2008 55 69 (Pubitemid 50000780)
19. S.W. Davies, M. Turmaine, B.A. Cozens, M. DiFiglia, A.H. Sharp, and C.A. Ross Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation Cell 90 1997 537 548 (Pubitemid 27347243)
20. K. Sathasivam, S. Baxendale, L. Mangiarini, F. Bertaux, C. Hetherington, and I. Kanazawa Aberrant processing of the Fugu HD (FrHD) mRNA in mouse cells and in transgenic mice Hum Mol Genet 6 1997 2141 2149 (Pubitemid 27477957)
21. M. DiFiglia, E. Sapp, K. Chase, C. Schwarz, A. Meloni, and C. Young Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons Neuron 14 1995 1075 1081
22. B. Lin, J.M. Rommens, R.K. Graham, M. Kalchman, H. MacDonald, and J. Nasir Differential 3′ polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expression Hum Mol Genet 2 1993 1541 1545 (Pubitemid 23358667)
23. B. Lin, J. Nasir, H. MacDonald, G. Hutchinson, R.K. Graham, and J.M. Rommens Sequence of the murine Huntington disease gene: evidence for conservation, alternate splicing and polymorphism in a triplet (CCG) repeat [corrected] Hum Mol Genet 3 1994 85 92 (Pubitemid 24038149)
24. Y. Trottier, D. Devys, G. Imbert, F. Saudou, I. An, and Y. Lutz Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form Nat Genet 10 1995 104 110
25. J. Nasir, S.B. Floresco, J.R. O'Kusky, V.M. Diewert, J.M. Richman, and J. Zeisler Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes Cell 81 1995 811 823
26. M.P. Duyao, A.B. Auerbach, A. Ryan, F. Persichetti, G.T. Barnes, and S.M. McNeil Inactivation of the mouse Huntington's disease gene homolog Hdh Science 269 1995 407 410
27. E.B. Clabough, and S.O. Zeitlin Deletion of the triplet repeat encoding polyglutamine within the mouse Huntington's disease gene results in subtle behavioral/motor phenotypes in vivo and elevated levels of ATP with cellular senescence in vitro Hum Mol Genet 15 2006 607 623 (Pubitemid 43205425)
28. M.A. Andrade, and P. Bork HEAT repeats in the Huntington's disease protein Nat Genet 11 1995 115 116
29. M. Tartari, C. Gissi, V. Lo Sardo, C. Zuccato, E. Picardi, and G. Pesole Phylogenetic comparison of huntingtin homologues reveals the appearance of a primitive polyQ in sea urchin Mol Biol Evol 25 2008 330 338 (Pubitemid 351231604)
30. M. DiFiglia, E. Sapp, K.O. Chase, S.W. Davies, G.P. Bates, and J.P. Vonsattel Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain Science 277 1997 1990 1993 (Pubitemid 27449140)
31. C. Landles, K. Sathasivam, A. Weiss, B. Woodman, H. Moffitt, and S. Finkbeiner Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease J Biol Chem 285 2010 8808 8823
32. M.W. Becher, J.A. Kotzuk, A.H. Sharp, S.W. Davies, G.P. Bates, and D.L. Price Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length Neurobiol Dis 4 1998 387 397 (Pubitemid 28201657)
33. J.M. Van Raamsdonk, Z. Murphy, E.J. Slow, B.R. Leavitt, and M.R. Hayden Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease Hum Mol Genet 14 2005 3823 3835 (Pubitemid 43020084)
34. J. Xia, D.H. Lee, J. Taylor, M. Vandelft, and R. Truant Huntingtin contains a highly conserved nuclear export signal Hum Mol Genet 12 2003 1393 1403 (Pubitemid 36758452)
35. J. Cornett, F. Cao, C.E. Wang, C.A. Ross, G.P. Bates, and S.H. Li Polyglutamine expansion of huntingtin impairs its nuclear export Nat Genet 37 2005 198 204
36. C.L. Wellington, L.M. Ellerby, A.S. Hackam, R.L. Margolis, M.A. Trifiro, and R. Singaraja Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract J Biol Chem 273 1998 9158 9167 (Pubitemid 28176206)
37. C.L. Wellington, R. Singaraja, L. Ellerby, J. Savill, S. Roy, and B. Leavitt Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells J Biol Chem 275 2000 19831 19838 (Pubitemid 30441585)
38. E. Hermel, J. Gafni, S.S. Propp, B.R. Leavitt, C.L. Wellington, and J.E. Young Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease Cell Death Differ 11 2004 424 438 (Pubitemid 38489420)
39. J. Gafni, and L.M. Ellerby Calpain activation in Huntington's disease J Neurosci 22 2002 4842 4849 (Pubitemid 37465599)
40. Y.J. Kim, Y. Yi, E. Sapp, Y. Wang, B. Cuiffo, and K.B. Kegel Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis Proc Natl Acad Sci USA 98 2001 12784 12789 (Pubitemid 33020022)
41. J.P. Miller, J. Holcomb, I. Al-Ramahi, M. de Haro, J. Gafni, and N. Zhang Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease Neuron 67 2010 199 212
42. R.K. Graham, Y. Deng, E.J. Slow, B. Haigh, N. Bissada, and G. Lu Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin Cell 125 2006 1179 1191 (Pubitemid 43866195)
43. J. Gafni, E. Hermel, J.E. Young, C.L. Wellington, M.R. Hayden, and L.M. Ellerby Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus J Biol Chem 279 2004 20211 20220 (Pubitemid 38623466)
44. M.A. Kalchman, R.K. Graham, G. Xia, H.B. Koide, J.G. Hodgson, and K.C. Graham Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme J Biol Chem 271 1996 19385 19394 (Pubitemid 26271610)
45. J.S. Steffan, N. Agrawal, J. Pallos, E. Rockabrand, L.C. Trotman, and N. Slepko SUMO modification of Huntingtin and Huntington's disease pathology Science 304 2004 100 104 (Pubitemid 38451465)
46. C.T. Aiken, J.S. Steffan, C.M. Guerrero, H. Khashwji, T. Lukacsovich, and D. Simmons Phosphorylation of threonine 3: implications for huntingtin aggregation and neurotoxicity J Biol Chem 284 2009 29427 29436
47. L.M. Thompson, C.T. Aiken, L.S. Kaltenbach, N. Agrawal, K. Illes, and A. Khoshnan IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome J Cell Biol 187 2009 1083 1099
48. X. Gu, E.R. Greiner, R. Mishra, R. Kodali, A. Osmand, and S. Finkbeiner Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice Neuron 64 2009 828 840
49. S. Humbert, E.A. Bryson, F.P. Cordelieres, N.C. Connors, S.R. Datta, and S. Finkbeiner The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt Dev Cell 2 2002 831 837 (Pubitemid 34650078)
50. S. Luo, C. Vacher, J.E. Davies, and D.C. Rubinsztein Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity J Cell Biol 169 2005 647 656 (Pubitemid 41002857)
51. S.C. Warby, E.Y. Chan, M. Metzler, L. Gan, R.R. Singaraja, and S.F. Crocker Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo Hum Mol Genet 14 2005 1569 1577 (Pubitemid 40823464)
52. S.L. Anne, F. Saudou, and S. Humbert Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons J Neurosci 27 2007 7318 7328 (Pubitemid 47037570)
53. H. Jeong, F. Then, T.J. Melia Jr., J.R. Mazzulli, L. Cui, and J.N. Savas Acetylation targets mutant huntingtin to autophagosomes for degradation Cell 137 2009 60 72
54. A. Yanai, K. Huang, R. Kang, R.R. Singaraja, P. Arstikaitis, and L. Gan Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function Nat Neurosci 9 2006 824 831
55. D. Rigamonti, J.H. Bauer, C. De-Fraja, L. Conti, S. Sipione, and C. Sciorati Wild-type huntingtin protects from apoptosis upstream of caspase-3 J Neurosci 20 2000 3705 3713 (Pubitemid 30266233)
56. Y. Zhang, M. Li, M. Drozda, M. Chen, S. Ren, and R.O. Mejia Sanchez Depletion of wild-type huntingtin in mouse models of neurologic diseases J Neurochem 87 2003 101 106 (Pubitemid 37210644)
57. B.R. Leavitt, J.M. van Raamsdonk, J. Shehadeh, H. Fernandes, Z. Murphy, and R.K. Graham Wild-type huntingtin protects neurons from excitotoxicity J Neurochem 96 2006 1121 1129
58. F.G. Gervais, R. Singaraja, S. Xanthoudakis, C.A. Gutekunst, B.R. Leavitt, and M. Metzler Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi Nat Cell Biol 4 2002 95 105 (Pubitemid 34141474)
59. D. Rigamonti, S. Sipione, D. Goffredo, C. Zuccato, E. Fossale, and E. Cattaneo Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing J Biol Chem 276 2001 14545 14548
60. C. Zuccato, A. Ciammola, D. Rigamonti, B.R. Leavitt, D. Goffredo, and L. Conti Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease Science 293 2001 493 498 (Pubitemid 32679077)
61. C. Zuccato, and E. Cattaneo Brain-derived neurotrophic factor in neurodegenerative diseases Nat Rev Neurol 5 2009 311 322
62. C. Zuccato, N. Belyaev, P. Conforti, L. Ooi, M. Tartari, and E. Papadimou Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease J Neurosci 27 2007 6972 6983 (Pubitemid 47015906)
63. C. Zuccato, M. Tartari, A. Crotti, D. Goffredo, M. Valenza, and L. Conti Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes Nat Genet 35 2003 76 83 (Pubitemid 37048599)
64. L.R. Gauthier, B.C. Charrin, M. Borrell-Pages, J.P. Dompierre, H. Rangone, and F.P. Cordelieres Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules Cell 118 2004 127 138 (Pubitemid 38902819)
65. L.S. Her, and L.S. Goldstein Enhanced sensitivity of striatal neurons to axonal transport defects induced by mutant huntingtin J Neurosci 28 2008 13662 13672
66. R. Smith, P. Brundin, and J.Y. Li Synaptic dysfunction in Huntington's disease: a new perspective Cell Mol Life Sci 62 2005 1901 1912 (Pubitemid 41261838)
67. P.W. Faber, J.R. Alter, M.E. MacDonald, and A.C. Hart Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron Proc Natl Acad Sci USA 96 1999 179 184 (Pubitemid 29036073)
68. J.A. Parker, J.B. Connolly, C. Wellington, M. Hayden, J. Dausset, and C. Neri Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death Proc Natl Acad Sci USA 98 2001 13318 13323 (Pubitemid 33051360)
69. S. Gunawardena, L.S. Her, R.G. Brusch, R.A. Laymon, I.R. Niesman, and B. Gordesky-Gold Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila Neuron 40 2003 25 40 (Pubitemid 37222462)
70. J.L. Marsh, and L.M. Thompson Drosophila in the study of neurodegenerative disease Neuron 52 2006 169 178 (Pubitemid 44479830)
71. V.M. Miller, R.F. Nelson, C.M. Gouvion, A. Williams, E. Rodriguez-Lebron, and S.Q. Harper CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo J Neurosci 25 2005 9152 9161 (Pubitemid 41500823)
72. L. Mangiarini, K. Sathasivam, M. Seller, B. Cozens, A. Harper, and C. Hetherington Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice Cell 87 1996 493 506 (Pubitemid 26374323)
73. G. Schilling, M.W. Becher, A.H. Sharp, H.A. Jinnah, K. Duan, and J.A. Kotzuk Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin Hum Mol Genet 8 1999 397 407 (Pubitemid 29097327)
74. J.G. Hodgson, N. Agopyan, C.A. Gutekunst, B.R. Leavitt, F. LePiane, and R. Singaraja A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration Neuron 23 1999 181 192 (Pubitemid 29262475)
75. E.J. Slow, J. van Raamsdonk, D. Rogers, S.H. Coleman, R.K. Graham, and Y. Deng Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease Hum Mol Genet 12 2003 1555 1567 (Pubitemid 36857303)
76. M. Gray, D.I. Shirasaki, C. Cepeda, V.M. Andre, B. Wilburn, and X.H. Lu Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice J Neurosci 28 2008 6182 6195
77. V.C. Wheeler, J.K. White, C.A. Gutekunst, V. Vrbanac, M. Weaver, and X.J. Li Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice Hum Mol Genet 9 2000 503 513 (Pubitemid 30154008)
78. C.H. Lin, S. Tallaksen-Greene, W.M. Chien, J.A. Cearley, W.S. Jackson, and A.B. Crouse Neurological abnormalities in a knock-in mouse model of Huntington's disease Hum Mol Genet 10 2001 137 144 (Pubitemid 32098123)
79. L.B. Menalled, J.D. Sison, I. Dragatsis, S. Zeitlin, and M.F. Chesselet Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats J Comp Neurol 465 2003 11 26 (Pubitemid 37075677)
80. S. von Horsten, I. Schmitt, H.P. Nguyen, C. Holzmann, T. Schmidt, and T. Walther Transgenic rat model of Huntington's disease Hum Mol Genet 12 2003 617 624 (Pubitemid 36372488)
81. S.H. Yang, P.H. Cheng, H. Banta, K. Piotrowska-Nitsche, J.J. Yang, and E.C. Cheng Towards a transgenic model of Huntington's disease in a non-human primate Nature 453 2008 921 924 (Pubitemid 351832563)
82. C.L. Wellington, L.M. Ellerby, C.A. Gutekunst, D. Rogers, S. Warby, and R.K. Graham Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease J Neurosci 22 2002 7862 7872 (Pubitemid 35379091)
83. K. Sathasivam, A. Lane, J. Legleiter, A. Warley, B. Woodman, and S. Finkbeiner Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease Hum Mol Genet 19 2010 65 78
84. J. Legleiter, E. Mitchell, G.P. Lotz, E. Sapp, C. Ng, and M. DiFiglia Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo J Biol Chem 285 2010 14777 14790
85. E. Sapp, C. Schwarz, K. Chase, P.G. Bhide, A.B. Young, and J. Penney Huntingtin localization in brains of normal and Huntington's disease patients Ann Neurol 42 1997 604 612 (Pubitemid 27439023)
86. E.E. Wanker Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations Biol Chem 381 2000 937 942
87. D. Martindale, A. Hackam, A. Wieczorek, L. Ellerby, C. Wellington, and K. McCutcheon Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates Nat Genet 18 1998 150 154 (Pubitemid 28082462)
88. A.S. Hackam, R. Singaraja, C.L. Wellington, M. Metzler, K. McCutcheon, and T.Q. Zhang The influence of Huntingtin protein size on nuclear localization and cellular toxicity J Cell Biol 141 1998 1097 1105 (Pubitemid 28265605)
89. S.H. Li, and X.J. Li Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats Hum Mol Genet 7 1998 777 782
90. S.M. Chen, F.A. Ferrone, and R. Wetzel Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation Proc Natl Acad Sci USA 99 2002 11884 11889 (Pubitemid 34994493)
91. C. Zuccato, M. Valenza, and E. Cattaneo Molecular mechanisms and potential therapeutical targets in Huntington's disease Physiol Rev 90 2010 905 981
92. C.A. Ross, and M.A. Poirier Opinion: what is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol 6 2005 891 898 (Pubitemid 41568738)
93. M. Arrasate, S. Mitra, E.S. Schweitzer, M.R. Segal, and S. Finkbeiner Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death Nature 431 2004 805 810 (Pubitemid 39434070)
94. A. Yamamoto, J.J. Lucas, and R. Hen Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease Cell 101 2000 57 66
95. M.A. Poirier, H. Li, J. Macosko, S. Cai, M. Amzel, and C.A. Ross Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization J Biol Chem 277 2002 41032 41037 (Pubitemid 35215693)
96. J.L. Wacker, M.H. Zareie, H. Fong, M. Sarikaya, and P.J. Muchowski Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer Nat Struct Mol Biol 11 2004 1215 1222
97. A.W. Dunah, H. Jeong, A. Griffin, Y.M. Kim, D.G. Standaert, and S.M. Hersch Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease Science 296 2002 2238 2243 (Pubitemid 34680312)
98. H. Okazawa Polyglutamine diseases: a transcription disorder? Cell Mol Life Sci 60 2003 1427 1439 (Pubitemid 36900524)
99. F.C. Nucifora Jr., M. Sasaki, M.F. Peters, H. Huang, J.K. Cooper, and M. Yamada Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity Science 291 2001 2423 2428 (Pubitemid 32231807)
100. L. Cui, H. Jeong, F. Borovecki, C.N. Parkhurst, N. Tanese, and D. Krainc Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration Cell 127 2006 59 69 (Pubitemid 44466642)
101. E. Trushina, and C.T. McMurray Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases Neuroscience 145 2007 1233 1248 (Pubitemid 46602738)
102. P.I. Moreira, X. Zhu, X. Wang, H.G. Lee, A. Nunomura, and R.B. Petersen Mitochondria: a therapeutic target in neurodegeneration Biochim Biophys Acta 1802 2010 212 220
103. F. Perez-Severiano, C. Rios, and J. Segovia Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease Brain Res 862 2000 234 237 (Pubitemid 30229791)
104. M.C. Polidori, P. Mecocci, S.E. Browne, U. Senin, and M.F. Beal Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex Neurosci Lett 272 1999 53 56
105. M.B. Bogdanov, O.A. Andreassen, A. Dedeoglu, R.J. Ferrante, and M.F. Beal Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease J Neurochem 79 2001 1246 1249 (Pubitemid 34019802)
106. S.E. Browne, A.C. Bowling, U. MacGarvey, M.J. Baik, S.C. Berger, and M.M. Muqit Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia Ann Neurol 41 1997 646 653 (Pubitemid 27212659)
107. S.E. Browne, R.J. Ferrante, and M.F. Beal Oxidative stress in Huntington's disease Brain Pathol 9 1999 147 163 (Pubitemid 29056525)
108. N. Brustovetsky, R. LaFrance, K.J. Purl, T. Brustovetsky, C.D. Keene, and W.C. Low Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's disease J Neurochem 93 2005 1361 1370 (Pubitemid 40853259)
109. A.V. Panov, C.A. Gutekunst, B.R. Leavitt, M.R. Hayden, J.R. Burke, and W.J. Strittmatter Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines Nat Neurosci 5 2002 731 736 (Pubitemid 34827590)
110. Y.S. Choo, G.V. Johnson, M. MacDonald, P.J. Detloff, and M. Lesort Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release Hum Mol Genet 13 2004 1407 1420 (Pubitemid 39023049)
111. A.L. Orr, S. Li, C.E. Wang, H. Li, J. Wang, and J. Rong N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking J Neurosci 28 2008 2783 2792 (Pubitemid 351398886)
112. I.S. Seong, E. Ivanova, J.M. Lee, Y.S. Choo, E. Fossale, and M. Anderson HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism Hum Mol Genet 14 2005 2871 2880 (Pubitemid 41418792)
113. B.G. Jenkins, W.J. Koroshetz, M.F. Beal, and B.R. Rosen Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy Neurology 43 1993 2689 2695 (Pubitemid 24004570)
114. J. Arenas, Y. Campos, R. Ribacoba, M.A. Martin, J.C. Rubio, and P. Ablanedo Complex I defect in muscle from patients with Huntington's disease Ann Neurol 43 1998 397 400 (Pubitemid 28113606)
115. S.E. Browne Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models Ann N Y Acad Sci 1147 2008 358 382
116. M. Gu, M.T. Gash, V.M. Mann, F. Javoy-Agid, J.M. Cooper, and A.H. Schapira Mitochondrial defect in Huntington's disease caudate nucleus Ann Neurol 39 1996 385 389 (Pubitemid 26100764)
117. T. Milakovic, R.A. Quintanilla, and G.V. Johnson Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences J Biol Chem 281 2006 34785 34795 (Pubitemid 46036517)
118. N.F. Bence, R.M. Sampat, and R.R. Kopito Impairment of the ubiquitin-proteasome system by protein aggregation Science 292 2001 1552 1555 (Pubitemid 32493425)
119. C.I. Holmberg, K.E. Staniszewski, K.N. Mensah, A. Matouschek, and R.I. Morimoto Inefficient degradation of truncated polyglutamine proteins by the proteasome EMBO J 23 2004 4307 4318 (Pubitemid 39546168)
120. T. Gidalevitz, A. Ben-Zvi, K.H. Ho, H.R. Brignull, and R.I. Morimoto Progressive disruption of cellular protein folding in models of polyglutamine diseases Science 311 2006 1471 1474 (Pubitemid 43376703)
121. S. Imarisio, J. Carmichael, V. Korolchuk, C.W. Chen, S. Saiki, and C. Rose Huntington's disease: from pathology and genetics to potential therapies Biochem J 412 2008 191 209 (Pubitemid 351758226)
122. P. Venkatraman, R. Wetzel, M. Tanaka, N. Nukina, and A.L. Goldberg Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins Mol Cell 14 2004 95 104 (Pubitemid 38469912)
123. J. Carmichael, J. Chatellier, A. Woolfson, C. Milstein, A.R. Fersht, and D.C. Rubinsztein Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease Proc Natl Acad Sci USA 97 2000 9701 9705 (Pubitemid 30650839)
124. J.M. Warrick, H.Y. Chan, G.L. Gray-Board, Y. Chai, H.L. Paulson, and N.M. Bonini Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70 Nat Genet 23 1999 425 428
125. A. Wyttenbach, J. Carmichael, J. Swartz, R.A. Furlong, Y. Narain, and J. Rankin Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease Proc Natl Acad Sci USA 97 2000 2898 2903 (Pubitemid 30159269)
126. B. Ravikumar, C. Vacher, Z. Berger, J.E. Davies, S. Luo, and L.G. Oroz Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease Nat Genet 36 2004 585 595 (Pubitemid 38715985)
127. S. Sarkar, and D.C. Rubinsztein Huntington's disease: degradation of mutant huntingtin by autophagy FEBS J 275 2008 4263 4270
128. K. Jia, A.C. Hart, and B. Levine Autophagy genes protect against disease caused by polyglutamine expansion proteins in Caenorhabditis elegans Autophagy 3 2007 21 25 (Pubitemid 46100705)
129. Y. Xie, M.R. Hayden, and B. Xu BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice J Neurosci 30 2010 14708 14718
130. G. Lynch, E.A. Kramar, C.S. Rex, Y. Jia, D. Chappas, and C.M. Gall Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease J Neurosci 27 2007 4424 4434 (Pubitemid 46640726)
131. J. St-Pierre, S. Drori, M. Uldry, J.M. Silvaggi, J. Rhee, and S. Jager Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators Cell 127 2006 397 408 (Pubitemid 44572377)
132. P. Weydt, V.V. Pineda, A.E. Torrence, R.T. Libby, T.F. Satterfield, and E.R. Lazarowski Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration Cell Metab 4 2006 349 362 (Pubitemid 44645069)
133. M. Minamiyama, M. Katsuno, H. Adachi, M. Waza, C. Sang, and Y. Kobayashi Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy Hum Mol Genet 13 2004 1183 1192 (Pubitemid 38787000)
134. E. Hockly, V.M. Richon, B. Woodman, D.L. Smith, X. Zhou, and E. Rosa Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease Proc Natl Acad Sci USA 100 2003 2041 2046 (Pubitemid 36254570)
135. R.J. Ferrante, J.K. Kubilus, J. Lee, H. Ryu, A. Beesen, and B. Zucker Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice J Neurosci 23 2003 9418 9427 (Pubitemid 37323042)
136. G. Gardian, S.E. Browne, D.K. Choi, P. Klivenyi, J. Gregorio, and J.K. Kubilus Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease J Biol Chem 280 2005 556 563 (Pubitemid 40165021)
137. J.S. Steffan, L. Bodai, J. Pallos, M. Poelman, A. McCampbell, and B.L. Apostol Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila Nature 413 2001 739 743 (Pubitemid 33009952)
138. C. Hubbert, A. Guardiola, R. Shao, Y. Kawaguchi, A. Ito, and A. Nixon HDAC6 is a microtubule-associated deacetylase Nature 417 2002 455 458 (Pubitemid 34563539)
139. J.J. Kovacs, P.J. Murphy, S. Gaillard, X. Zhao, J.T. Wu, and C.V. Nicchitta HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor Mol Cell 18 2005 601 607 (Pubitemid 40726236)
140. A. Iwata, B.E. Riley, J.A. Johnston, and R.R. Kopito HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin J Biol Chem 280 2005 40282 40292 (Pubitemid 41779165)
141. F. Giorgini, T. Moller, W. Kwan, D. Zwilling, J.L. Wacker, and S. Hong Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment J Biol Chem 283 2008 7390 7400
142. O.A. Andreassen, A. Dedeoglu, R.J. Ferrante, B.G. Jenkins, K.L. Ferrante, and M. Thomas Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease Neurobiol Dis 8 2001 479 491 (Pubitemid 32566138)
143. R.J. Ferrante, O.A. Andreassen, B.G. Jenkins, A. Dedeoglu, S. Kuemmerle, and J.K. Kubilus Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease J Neurosci 20 2000 4389 4397 (Pubitemid 30396603)
144. R.J. Ferrante, O.A. Andreassen, A. Dedeoglu, K.L. Ferrante, B.G. Jenkins, and S.M. Hersch Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease J Neurosci 22 2002 1592 1599 (Pubitemid 35386278)
145. G. Schilling, M.L. Coonfield, C.A. Ross, and D.R. Borchelt Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model Neurosci Lett 315 2001 149 153 (Pubitemid 33079072)
146. Huntington Study Group A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease Neurology 57 2001 397 404
147. P. Verbessem, J. Lemiere, B.O. Eijnde, S. Swinnen, L. Vanhees, and M. Van Leemputte Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial Neurology 61 2003 925 930 (Pubitemid 37248646)
148. M. Chen, V.O. Ona, M. Li, R.J. Ferrante, K.B. Fink, and S. Zhu Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease Nat Med 6 2000 797 801 (Pubitemid 30469429)
149. X. Wang, S. Zhu, M. Drozda, W. Zhang, I.G. Stavrovskaya, and E. Cattaneo Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease Proc Natl Acad Sci USA 100 2003 10483 10487 (Pubitemid 37071904)
150. D.C. Rubinsztein, J.E. Gestwicki, L.O. Murphy, and D.J. Klionsky Potential therapeutic applications of autophagy Nat Rev Drug Discov 6 2007 304 312 (Pubitemid 46505881)
151. B. Ravikumar, R. Duden, and D.C. Rubinsztein Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy Hum Mol Genet 11 2002 1107 1117 (Pubitemid 34521091)
152. Z. Berger, B. Ravikumar, F.M. Menzies, L.G. Oroz, B.R. Underwood, and M.N. Pangalos Rapamycin alleviates toxicity of different aggregate-prone proteins Hum Mol Genet 15 2006 433 442 (Pubitemid 43159895)
153. M. Coufal, M.M. Maxwell, D.E. Russel, A.M. Amore, S.M. Altmann, and Z.R. Hollingsworth Discovery of a novel small-molecule targeting selective clearance of mutant huntingtin fragments J Biomol Screen 12 2007 351 360 (Pubitemid 46514677)
154. S. Sarkar, E.O. Perlstein, S. Imarisio, S. Pineau, A. Cordenier, and R.L. Maglathlin Small molecules enhance autophagy and reduce toxicity in Huntington's disease models Nat Chem Biol 3 2007 331 338 (Pubitemid 46789270)
155. S. Sarkar, G. Krishna, S. Imarisio, S. Saiki, C.J. O'Kane, and D.C. Rubinsztein A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin Hum Mol Genet 17 2008 170 178
156. V. Heiser, E. Scherzinger, A. Boeddrich, E. Nordhoff, R. Lurz, and N. Schugardt Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy Proc Natl Acad Sci USA 97 2000 6739 6744 (Pubitemid 30412784)
157. X. Zhang, D.L. Smith, A.B. Meriin, S. Engemann, D.E. Russel, and M. Roark A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo Proc Natl Acad Sci USA 102 2005 892 897 (Pubitemid 40282761)
158. U.A. Desai, J. Pallos, A.A. Ma, B.R. Stockwell, L.M. Thompson, and J.L. Marsh Biologically active molecules that reduce polyglutamine aggregation and toxicity Hum Mol Genet 15 2006 2114 2124 (Pubitemid 43923401)
159. S.K. Pollitt, J. Pallos, J. Shao, U.A. Desai, A.A. Ma, and L.M. Thompson A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor Neuron 40 2003 685 694 (Pubitemid 37431030)
160. M. Li, Y. Huang, A.A. Ma, E. Lin, and M.I. Diamond Y-27632 improves rotarod performance and reduces huntingtin levels in R6/2 mice Neurobiol Dis 36 2009 413 420
161. M. Tanaka, Y. Machida, S. Niu, T. Ikeda, N.R. Jana, and H. Doi Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease Nat Med 10 2004 148 154 (Pubitemid 38524884)
162. A. Sittler, R. Lurz, G. Lueder, J. Priller, H. Lehrach, and M.K. Hayer-Hartl Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease Hum Mol Genet 10 2001 1307 1315 (Pubitemid 32600484)
163. D.G. Hay, K. Sathasivam, S. Tobaben, B. Stahl, M. Marber, and R. Mestril Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach Hum Mol Genet 13 2004 1389 1405 (Pubitemid 38961645)
164. M. Katsuno, C. Sang, H. Adachi, M. Minamiyama, M. Waza, and F. Tanaka Pharmacological induction of heat-shock proteins alleviates polyglutamine- mediated motor neuron disease Proc Natl Acad Sci USA 102 2005 16801 16806 (Pubitemid 41688857)
165. H. Xia, Q. Mao, S.L. Eliason, S.Q. Harper, I.H. Martins, and H.T. Orr RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia Nat Med 10 2004 816 820 (Pubitemid 39070854)
166. S.Q. Harper, P.D. Staber, X. He, S.L. Eliason, I.H. Martins, and Q. Mao RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model Proc Natl Acad Sci USA 102 2005 5820 5825 (Pubitemid 40559643)
167. J. Hu, M. Matsui, K.T. Gagnon, J.C. Schwartz, S. Gabillet, and K. Arar Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs Nat Biotechnol 27 2009 478 484
168. E.M. Denovan-Wright, E. Rodriguez-Lebron, A.S. Lewin, and R.J. Mandel Unexpected off-targeting effects of anti-huntingtin ribozymes and siRNA in vivo Neurobiol Dis 29 2008 446 455
169. A.L. Jackson, S.R. Bartz, J. Schelter, S.V. Kobayashi, J. Burchard, and M. Mao Expression profiling reveals off-target gene regulation by RNAi Nat Biotechnol 21 2003 635 637 (Pubitemid 36638089)
170. D.W. Colby, Y. Chu, J.P. Cassady, M. Duennwald, H. Zazulak, and J.M. Webster Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody Proc Natl Acad Sci USA 101 2004 17616 17621 (Pubitemid 40051935)
171. A. Khoshnan, J. Ko, and P.H. Patterson Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity Proc Natl Acad Sci USA 99 2002 1002 1007 (Pubitemid 34106625)
172. J.A. McLear, D. Lebrecht, A. Messer, and W.J. Wolfgang Combinational approach of intrabody with enhanced Hsp70 expression addresses multiple pathologies in a fly model of Huntington's disease FASEB J 22 2008 2003 2011 (Pubitemid 351811476)
173. C.E. Wang, H. Zhou, J.R. McGuire, V. Cerullo, B. Lee, and S.H. Li Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin J Cell Biol 181 2008 803 816 (Pubitemid 351786985)
174. A. Kazantsev, H.A. Walker, N. Slepko, J.E. Bear, E. Preisinger, and J.S. Steffan A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila Nat Genet 30 2002 367 376